The robots are coming to medtech: Where’s the value? (Medical Design & Outsourcing)
As each medtech manufacturer gears up to bring robots to surgery, they’ll need to create an outcomes-oriented value story in order to compete.
The biggest medtech headlines so far in 2019 tell a consistent story: The robots are coming.
From Medtronic’s $1.6 billion acquisition of Mazor in late December to Johnson & Johnson dropping $3.4 billion to acquire Auris Health in the first quarter, many major players are making significant investments in robotics. T
The robot-assisted surgery market is estimated to reach $5.6 billion by 2025, according to Grand View Research. The market is poised for explosive growth, and for good reason: Robotic innovations are dramatically reshaping the practice of surgery, with the potential to be leveraged from diagnosis to incision.
Robotics in medtech: Evolution or revolution?
The growth in robotics could start to fill operating theaters with ever more highly specialized capital equipment. With one-third of hospitals in the U.S. already running at least one robot, will the gap continue to widen between hospitals that specialize ...
